Joseph H. Capper
CIK: 0001456817
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 15, 2026TELA
TELA Bio, Inc.
Award(A)Direct19.8K shares at avg. $1.01$20K - Sep 17, 2026TELA
TELA Bio, Inc.
Purchase(P)Direct25K shares at avg. $1.22$31K - Sep 16, 2026TELA
TELA Bio, Inc.
Purchase(P)Direct50K shares at avg. $1.17$58K - Sep 15, 2026TELA
TELA Bio, Inc.
Purchase(P)Direct50K shares at avg. $1.06$53K - Sep 14, 2026TELA
TELA Bio, Inc.
Purchase(P)Direct25K shares at avg. $1.02$26K - Jul 15, 2026TELA
TELA Bio, Inc.
Award(A)Direct6.2K shares at avg. $0.79$5K - Jun 18, 2026ANIK
Anika Therapeutics, Inc.
Award(A)Direct10.4K shares- - Jun 9, 2026TELA
TELA Bio, Inc.
Award(A)Direct11.9K shares- - Jun 9, 2026TELA
TELA Bio, Inc.
Award(A)Direct11.7K shares- - Mar 4, 2026MDXG
MIMEDX GROUP, INC.
Award(A)Direct371.1K shares- - Jun 20, 2025ANIK
Anika Therapeutics, Inc.
Award(A)Direct14.2K shares- - May 2, 2025MDXG
MIMEDX GROUP, INC.
Purchase(P)Direct200K shares at avg. $6.34$1.3M - Mar 3, 2025MDXG
MIMEDX GROUP, INC.
Award(A)Direct223.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 |  TELA TELA Bio, Inc. | Award(A) | 19,801 | $1.01 | $19,999 | Direct |
| Sep 17, 2026 | TELA TELA Bio, Inc. | Purchase(P) | 25,000 | $1.22 | $30,530 | Direct |
| Sep 16, 2026 | TELA TELA Bio, Inc. | Purchase(P) | 50,000 | $1.17 | $58,265 | Direct |
| Sep 15, 2026 | TELA TELA Bio, Inc. | Purchase(P) | 50,000 | $1.06 | $52,940 | Direct |
| Sep 14, 2026 | TELA TELA Bio, Inc. | Purchase(P) | 25,000 | $1.02 | $25,503 | Direct |
| Jul 15, 2026 | TELA TELA Bio, Inc. | Award(A) | 6,227 | $0.79 | $4,888 | Direct |
| Jun 18, 2026 |  ANIK Anika Therapeutics, Inc. | Award(A) | 10,402 | - | $0 | Direct |
| Jun 9, 2026 | TELA TELA Bio, Inc. | Award(A) | 11,925 | - | $0 | Direct |
| Jun 9, 2026 | TELA TELA Bio, Inc. | Award(A) | 11,675 | - | $0 | Direct |
| Mar 4, 2026 |  MDXG MIMEDX GROUP, INC. | Award(A) | 371,094 | - | $0 | Direct |
| Jun 20, 2025 | ANIK Anika Therapeutics, Inc. | Award(A) | 14,164 | - | - | Direct |
| May 2, 2025 | MDXG MIMEDX GROUP, INC. | Purchase(P) | 200,000 | $6.34 | $1,268,000 | Direct |
| Mar 3, 2025 | MDXG MIMEDX GROUP, INC. | Award(A) | 223,268 | - | - | Direct |
1-13 of 13 transactions
About Capper Joseph H
Capper Joseph H (SEC CIK 0001456817) files insider reports with the SEC as Director of TELA Bio, Inc. (TELA), Director of Anika Therapeutics, Inc. (ANIK) and Chief Executive Officer of MIMEDX GROUP, INC. (MDXG).
Signal8 holds 11 ownership filings by Capper Joseph H (1 Form 3, 10 Form 4), filed between Mar 5, 2025 and Oct 19, 2026. Those filings report 13 transactions, from Mar 3, 2025 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Capper Joseph H's filings is in MALVERN, PA.
Recent filings by Capper Joseph H
- Oct 15, 2026: Grant or award of TELA shares (Form 4, code A).
- Sep 17, 2026: Open-market purchase of TELA shares (Form 4, code P).
- Sep 16, 2026: Open-market purchase of TELA shares (Form 4, code P).
- Sep 15, 2026: Open-market purchase of TELA shares (Form 4, code P).
- Sep 14, 2026: Open-market purchase of TELA shares (Form 4, code P).
Other insiders filing for TELA Bio, Inc. (TELA)
- Plovanic William J., Director
- Getz Heather C, Chief Executive Officer
- Rocchio Betty Jo, Director
- NEELS GUIDO J, Director
- THOMAS PAUL, Director
- NOHRA GUY P, Director